The University of Texas Medical Branch, Galveston
utmb.eduLive pipeline data from ClinicalTrials.gov, refreshed daily.
Total trials
252
Active
46
Phase 3
24
Total enrollment
37,554
Pipeline matrix
Showing 16 of 16 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| 9-valent HPV vaccine, 3 doses standard timing | — | — | — | — | — | 2 | |
| Rocuronium | — | — | — | — | — | 1 | |
| Cisatracurium | — | — | — | — | — | 1 | |
| Sugammadex | — | — | — | — | — | 1 | |
| Neostigmine | — | — | — | — | — | 1 | |
| 9-valent HPV vaccine, 2 doses alternate timing | — | — | — | — | — | 1 | |
| Sildenafil | — | — | — | 6 | |||
| Famotidine and 4% topical cromolyn sodium | — | — | — | — | — | 1 | |
| Azeliragon | — | — | — | — | — | 1 | |
| Research Grade RG-RV | — | — | — | — | — | 1 | |
| Lidocaine | — | — | — | — | — | 1 | |
| Lidocaine and Dexamethasone | — | — | — | — | — | 1 | |
| Zepbound | — | — | — | — | — | 1 | |
| Sildenafil Citrate | — | — | — | — | — | 1 | |
| anodal transcranial direct current stimulation | — | — | — | — | — | 2 | |
| Hemin | — | — | — | — | — | 1 |
Next readouts
- 2020-03-01
- 2026-04
- 2026-08
- 2026-08-30
- 2026-08-31
- 2026-12
- 2026-12-01
- 2026-12-31
- 2026-12-31
- 2027-05-01
Top conditions
- Aging12
- Burns11
- Burn10
- Breast Cancer9
- Stroke8
- Sarcopenia8
- Diabetes Mellitus, Type 27
- Traumatic Brain Injury7
Frequently asked questions about The University of Texas Medical Branch, Galveston
- How many clinical trials does The University of Texas Medical Branch, Galveston have on ClinicalTrials.gov?
- The University of Texas Medical Branch, Galveston is listed as the lead sponsor on 252 clinical trials in ClinicalTrials.gov, 46 of which are currently active (recruiting, enrolling, or ongoing).
- How many of The University of Texas Medical Branch, Galveston's trials are in Phase 3?
- 24 of The University of Texas Medical Branch, Galveston's trials are in Phase 3, spread across 16 active drug programs.
- What therapeutic areas does The University of Texas Medical Branch, Galveston focus on?
- The University of Texas Medical Branch, Galveston's most-studied conditions on ClinicalTrials.gov are Aging, Burns, Burn, Breast Cancer, Stroke.
- When are The University of Texas Medical Branch, Galveston's next clinical trial readouts?
- The University of Texas Medical Branch, Galveston has 10 upcoming primary-completion readouts tracked here; the soonest is “Use of Sildenafil for Treatment of Urinary Incontinence”, expected around 2020-03-01.